Skip to main content
PRQRSector not reported

ProQR Therapeutics N.V (PRQR) Insider Trading

In the last 90 days, no ProQR Therapeutics N.V (PRQR) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jul 31, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 31, 2026Boer Daniel Anton deChief Executive OfficerOpen Market Purchase200,000$1.77$353,960
Jul 17, 2026Bart FiliusCorporate insiderOpen Market Purchase150,000$1.72$257,925
Jul 9, 2026Boer Daniel Anton deChief Executive OfficerOpen Market Purchase150,000$1.74$261,000
Jul 7, 2026Boer Daniel Anton deChief Executive OfficerOpen Market Purchase150,000$1.59$238,500
Jun 26, 2026Bart FiliusCorporate insiderOpen Market Purchase150,000$1.54$231,000

Common questions

PRQR insider trading FAQ

Are PRQR insiders buying or selling?
No PRQR insiders reported open-market purchases or sales in the last 90 days.
When was the last PRQR insider purchase?
No open-market insider purchase of ProQR Therapeutics N.V stock was reported in the last 90 days.
Where does PRQR insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that ProQR Therapeutics N.V officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.